{"news_desk": "National", "print_page": "1", "subsection_name": "Politics", "section_name": "U.S.", "byline": {"contributor": "Doris Burke contributed research.", "original": "By SHERI FINK, STEVE EDER and MATTHEW GOLDSTEIN", "person": [{"firstname": "Sheri", "rank": 1, "lastname": "FINK", "organization": "", "role": "reported"}, {"firstname": "Steve", "rank": 2, "lastname": "EDER", "organization": "", "role": "reported"}, {"firstname": "Matthew", "rank": 3, "lastname": "GOLDSTEIN", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "1648", "keywords": [{"rank": "1", "value": "DeVos, Elizabeth (1958- )", "is_major": "N", "name": "persons"}, {"rank": "2", "value": "DeVos, Dick", "is_major": "N", "name": "persons"}, {"rank": "3", "value": "Psychology and Psychologists", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Brain", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "Neurocore LLC", "is_major": "N", "name": "organizations"}], "lead_paragraph": "The nominee for education secretary is a chief investor in Neurocore, a group of brain performance centers whose methods have been questioned.", "pub_date": "2017-01-31T04:30:51+0000", "document_type": "article", "source": "The New York Times", "snippet": "The nominee for education secretary is a chief investor in Neurocore, a group of brain performance centers whose methods have been questioned....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2017/01/31/us/31neurocore-02/31neurocore-02-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2017/01/31/us/31neurocore-02/31neurocore-02-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2017/01/31/us/31neurocore-02/31neurocore-02-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2017/01/31/us/31neurocore-02/31neurocore-02-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2017/01/31/us/31neurocore-02/31neurocore-02-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2017/01/31/us/31neurocore-02/31neurocore-02-thumbStandard-v2.jpg"}], "web_url": "http://www.nytimes.com/2017/01/30/us/politics/betsy-devos-neurocore-brain-centers.html", "slideshow_credits": null, "blog": [], "_id": "5890130595d0e0392607dad3", "headline": {"main": "Betsy DeVos Invests in a Therapy Under Scrutiny", "print_headline": "DeVos Invests in a Therapy Under Doubt"}}